BHC — Bausch Health Companies Inc. Stock Price, Chart & AI Report

Positive Feb 18, 2026 • 09:00 UTC GlobeNewswire Inc. • Sns Insider

Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally

The global scar treatment market is projected to grow from USD 26.60 billion in 2025 to USD 56.30 billion by 2033, with a CAGR of 9.91%. Growth is driven by increasing awareness of advanced cosmetic and reconstructive procedures, rising prevalence of acne, surgical, and traumatic scars, and technological advancements in minimally invasive treatments. The U.S. market alone is expected to reach USD 17.69 billion by 2033.

SNN JNJ PRGO BHC scar treatment market cosmetic procedures laser therapy topical treatments

Sentiment note

Major player in the scar treatment market positioned to benefit from growing demand for advanced cosmetic and dermatological procedures.

Positive Feb 17, 2026 • 09:58 UTC GlobeNewswire Inc. • Researchandmarkets.Com

Energy-Based Aesthetic Devices Market Research Report 2026-2031: Advancements in Laser and RF Systems, Rising Consumer Demand and Geographic Expansion Accelerate Revenue Opportunities

The Energy-Based Aesthetic Devices Market is projected to grow from USD 7.03 billion in 2025 to USD 11.80 billion by 2031 at a CAGR of 9.02%. Growth is driven by increased demand for hair removal treatments, med-spa expansion, minimally invasive procedures, and AI integration. Laser-based technology dominates the market, with North America leading globally. Key challenges include rising health and wellness awareness and high device costs.

BHC INMD energy-based aesthetic devices laser technology hair removal med-spa minimally invasive treatments AI integration

Sentiment note

Listed as a major vendor competing in the growing energy-based aesthetic devices market with strong market positioning and strategic focus on technology and after-sales services.

Positive Dec 7, 2025 • 13:05 UTC GlobeNewswire Inc. • Sns Insider

Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider

The global ophthalmic drugs market is projected to grow from USD 37.35 billion in 2023 to USD 62.74 billion by 2032, driven by increasing eye disorders, advanced drug delivery methods, and rising healthcare awareness.

ABBV ALC BHC NVS ophthalmic drugs eye care healthcare market medical innovation

Sentiment note

Acquired Novartis' 'front of eye' ophthalmology assets, indicating strategic market expansion

Positive Dec 2, 2025 • 00:02 UTC The Motley Fool • Eric Volkman

Why Bausch Health Companies Stock Rocketed 11% Higher Today

Bausch Health Companies' stock rose 11% after acquiring Wuhan Shibo Zhenmei Technology, a distributor of its aesthetic products in China, which enhances its market presence in the region.

BHC acquisition aesthetics China Solta Medical Thermage FLX

Sentiment note

Stock price increased by 11% due to strategic acquisition of a local distributor in China, which provides enhanced market control and potential growth in the aesthetic treatments market

Positive Dec 1, 2025 • 21:34 UTC The Motley Fool • Dan Caplinger

Biggest Stock Movers Today, Dec. 1: BHC, SMR, & More

Stock markets experienced a mixed day with major indexes declining, while individual stocks showed significant movements. Healthcare and technology stocks saw notable performance changes, with some companies experiencing substantial gains or losses.

BHC ASH SMR BMNR stock market market movers healthcare stocks cryptocurrency

Sentiment note

Stock rose 11.34% after completing an acquisition of Wuhan Shibo Zhenmei Technology, which helps expand distribution in the Chinese market

Neutral Oct 31, 2025 • 17:48 UTC Investing.com • Jesse Cohen

5 Undervalued Stocks Under $10 Poised for Double-Digit Rebounds

The article highlights five stocks trading under $10 that show potential for significant price appreciation, driven by factors like user growth, economic recovery, and strategic improvements in their respective industries.

SNAP MLCO BHC WEN undervalued stocks stock market investment opportunities turnaround stocks

Sentiment note

Carrying past baggage, but has diversified portfolio, stable cash flows, and potential for debt refinancing

Positive Sep 11, 2025 • 03:30 UTC GlobeNewswire Inc. • Linda Lam

Questex’s Fierce Pharma Announces the 2025 Fierce Pharma Marketing Awards Winners

Questex's Fierce Pharma Marketing Awards celebrated innovative pharmaceutical marketing campaigns across 18 categories, highlighting creative approaches to addressing global health challenges.

SNY BHC ACAD PFE pharmaceutical marketing healthcare innovation awards marketing campaigns

Sentiment note

Won Impiricus HCP Impact Award and Marketer of the Year for Xiidra product

Neutral Sep 9, 2025 • 14:00 UTC GlobeNewswire Inc. • Towards Healthcare

Basal Cell Carcinoma Treatment Market to Reach USD 9.01 Billion by 2034, Reports Towards Healthcare

The global basal cell carcinoma treatment market is expected to grow from USD 3.33 billion in 2024 to USD 9.01 billion by 2034, with a CAGR of 10.48%. North America dominates the market, and technological advancements in treatment are driving market expansion.

BHC NVS REGN basal cell carcinoma skin cancer treatment market healthcare innovation medical technology

Sentiment note

Mentioned as a key market player without specific performance details

Positive Sep 1, 2025 • 14:00 UTC GlobeNewswire Inc. • Towards Healthcare

Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034

The global acne medication market is expected to grow from USD 14.86 billion in 2025 to USD 23.33 billion by 2034, with a 5.14% CAGR. North America dominates the market, driven by high acne prevalence, innovative treatments, and strong pharmaceutical presence.

GSK BHC JNJ PFE acne medication dermatology pharmaceutical market skincare

Sentiment note

Recently launched new topical prescription acne treatment, indicating active market participation and innovation

Neutral Aug 12, 2025 • 18:11 UTC Benzinga • Prnewswire

IBS in America: Despite advances, IBS remains a burden for many millions

A new AGA-sponsored survey reveals that IBS symptoms continue to significantly disrupt patients' daily lives, with symptoms interfering with work and personal activities for nearly 19 days per month, despite increased awareness and treatment advancements.

STGW BHC IBS healthcare patient survey gastroenterology medical research

Sentiment note

Mentioned as providing support for the survey through Salix Medical Affairs division, with no specific impact on company perception

Positive Jul 29, 2025 • 18:21 UTC Benzinga • Vandana Singh

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

Bausch Health will acquire DURECT for $63 million upfront, gaining rights to larsucosterol, a promising drug candidate for treating alcoholic hepatitis, with potential additional milestone payments of up to $350 million.

BHC DRRX acquisition liver disease pharmaceutical drug development alcoholic hepatitis

Sentiment note

Expanding clinical portfolio with a novel therapeutic molecule targeting an unmet medical need, with potential for significant milestone payments

Positive Apr 8, 2025 • 08:52 UTC GlobeNewswire Inc. • Researchandmarkets.Com

Ophthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities

The global ophthalmology market is expected to grow at a CAGR of 6.62%, reaching $93.69 billion by 2030, driven by advancements in technology, personalized medicine, and improved healthcare access.

ABBV ALC BHC ESLOY ophthalmology market growth technology personalized medicine

Sentiment note

Bausch Health Companies Inc. is mentioned as one of the influential players in the ophthalmology market, signaling its importance and potential for further growth.